Skyscape Web Viewer : Targeted Cancer Therapy A Handbook for Nurses : Main Index

View All
Mesynchymal-epithelial transition Application Of The Hallmarks Of Cancer Hepatocyte Growth Factor (Hgf/C-Met) Receptor Pathway Targets Invasion and Metastasis Membrane-Bound Receptor Kinases (E.g., Egfr, Her2, Hgf/C-Met, Igfr Pathways)
Mesynchymal-epithelial transition factor Hepatocyte Growth Factor (Hgf/C-Met) Receptor Pathway Targets Membrane-Bound Receptor Kinases (E.g., Egfr, Her2, Hgf/C-Met, Igfr Pathways)
MET,
Metalloproteinase inhibitors
Metaprolol, gefitinib coadministered with
Metastasis invasion and learning more about overexpression of HER family receptors and
Metastasis,
Methylation, comparison of
Methylation in DNA, modification of
mFOLFOX6 Nursing Considerations and Drug Information References (Chapter 3)
Microarray in Node-Negative Disease May Avoid Chemotherapy trial
Microenvironment
Micrometastasis, movement to macrometastasis
MicroRNA (miRNA) Chapter 2. Targeted Cancer Therapy: External and Internal Signaling Pathway Targets Invasion and Metastasis learning about specific function of malignancy states and
Microsatellite instability Application Of The Hallmarks Of Cancer References
Microsatellites, defined
Microvessel density References (Chapter 3) Targeting Angiogenesis
Midostaurin (PKC412, investigational) adverse reactions class dosage and administration drug interactions mechanism of action Nursing Considerations and Drug Information reconstitution and preparation
MIP-1α,
Mismatch repair genes, mutations in both copies of
Mitochondria, apoptosis and
Mitogen-activated protein kinase Application Of The Hallmarks Of Cancer Bone Metastasis Chapter 2. Targeted Cancer Therapy: External and Internal Signaling Pathway Targets Glossary Targeting Angiogenesis
Mitosis Application Of The Hallmarks Of Cancer Chapter 4. Targeting the Microenvironment: Bone Metastasis, Apoptosis, DNA Repair, and Mitosis Epigenetic Abnormalities (Dna Methyltransferase and Histone Deacetylase) Glossary Introduction Membrane-Bound Receptor Kinases (E.g., Egfr, Her2, Hgf/C-Met, Igfr Pathways) Mitotic Kinase Inhibitors Protein Dynamics: Heat Shock Proteins and Ubiquitin - Proteasome Inhibitors Protein Kinase Signaling Pathways Targeting Apoptosis
Mitosis phase
Mitotic kinase inhibitors Dna Repair Gene Mutations: Opportunities From Synthetic Lethality Mitotic Kinase Inhibitors Summary (Chapter 4)
Mitotic machinery, therapeutic targeting of
Mitotic spindle Application Of The Hallmarks Of Cancer Glossary Mitotic Kinase Inhibitors
MK-0457
MLH1 gene Application Of The Hallmarks Of Cancer Epigenetics
MMP-12